1.05 +0.00 (0.00%)
PPHM
| Trade PPHM now with |
|
Stock Details
Last Trade:1.05 Change:+0.00 (0.00%) Prev Close:1.05 Open: 1.12 Days Range:1.02 – 1.14 52 Week Range: 0.85 - 2.74 Volume:4740140 P/E: N/AEPS:-0.56
View AllRecent Alerts 02/09/12
Recent Alert on 01/23/12 at 11:10am
Morning Movers 01/23: (MFN) (YRCW) (SCHS) (CTIC) Higher; (TWIN) (ALXA) (MLNX) Lower
Morning Movers 01/23: (MFN) (YRCW) (SCHS) (CTIC) Higher; (TWIN) (ALXA) (MLNX) Lower
Minefinders (AMEX: MFN) 24.2% HIGHER; Pan American (Nasdaq: PAAS) confirms offer to acquire Minefinders at C$15.60 per share, or about C$1.5 billion. The deal is made up of 0.6235 shares or all cash. YRC Worldwide (Nasdaq: YRCW) 19.9% HIGHER;... Read More
Recent Alert on 12/29/11 at 8:02am
Peregrine (PPHM) Reports Encouraging Data from Bavituximab Phase II in HCV Patients; Appears Safe, Well Tolerated
Peregrine (PPHM) Reports Encouraging Data from Bavituximab Phase II in HCV Patients; Appears Safe, Well Tolerated
Recent Alert on 12/29/11 at 8:02am
Peregrine (PPHM) Reports Encouraging Data from Bavituximab Phase II in HCV Patients; Appears Safe, Well Tolerated
Peregrine (PPHM) Reports Encouraging Data from Bavituximab Phase II in HCV Patients; Appears Safe, Well Tolerated
Recent Alert on 12/12/11 at 4:09pm
Peregrine Pharmaceuticals, Inc. (PPHM) Misses Q2 Loss Views; Revs Stronger
Peregrine Pharmaceuticals, Inc. (PPHM) Misses Q2 Loss Views; Revs Stronger
Recent Alert on 12/09/11 at 3:27pm
Trading Radar for 12/12: Fuelcell Energy (FCEL), Avanir Pharma (AVNR), Peregrine Pharma (PPHM), Miller Energy (MILL) Report
Trading Radar for 12/12: Fuelcell Energy (FCEL), Avanir Pharma (AVNR), Peregrine Pharma (PPHM), Miller Energy (MILL) Report
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/22/11 at 11:51am
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data